© 2008, Columbia Laboratories, Inc. All rights reserved.

 

Please note that the product information provided on this website is intended only for residents of the United States.

In IVF-ET cycles—

 

Pregnancy Rates Comparable to IM Progesterone1

 

Study design: Results of a retrospective analysis of 118 IVF-ET cycles over a 2-year period in which women received progesterone for luteal phase support. Starting on the day of oocyte retrieval, patients received Crinone 8% (90 mg QD, exclusive of IM progesterone use) or IM progesterone (50 mg QD, exclusive of Crinone 8% use).

 

Reference: 1. Coutifaris C, Patrizio P, Schafer D, Bunso S, Bucci J, Barnhart K. Is the use of Crinone for support of the luteal phase detrimental to pregnancy outcome after transfer of non-cryopreserved embryos in good prognosis patients? A preliminary report. Fertil Steril. 2000;74(suppl 1):S205. Abstract P-350.